| |
| |
|
| Insider
Information: |
Sherman Michael A. |
| Relationship: |
Director |
| City: |
West Lafayette |
| State: |
IN |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
233,413 |
|
|
Indirect Shares
|
189,995 |
|
|
| Direct
Value |
$226,364 |
|
|
|
Indirect Value
|
$184,257 |
|
|
| Total
Shares |
423,408 |
|
|
| Total
Value |
$410,621 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 65.2%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Endocyte Inc |
ECYT |
President and CEO, Dir... |
2018-12-21 |
0 |
2018-12-21 |
0 |
Premium* |
|
|
Mead Johnson Nutrition Co |
MJN |
Director |
2017-06-15 |
0 |
2016-02-26 |
0 |
Premium* |
|
|
Chimerix Inc |
CMRX |
Chief Executive Office... |
2023-05-12 |
233,413 |
2023-05-12 |
189,995 |
Premium* |
|
|
Biospecifics Technologies Corp |
BSTC |
Director |
2020-12-02 |
0 |
2020-04-13 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
32 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ECYT |
Endocyte Inc |
President and CEO |
• • – |
2018-12-21 |
4 |
D |
$24.00 |
$478,056 |
I/I |
(19,919) |
0 |
0 |
- |
|
| ECYT |
Endocyte Inc |
President, CEO and CFO |
• • – |
2016-06-16 |
4 |
A |
$0.00 |
$0 |
D/D |
10,000 |
136,360 |
0 |
- |
|
| ECYT |
Endocyte Inc |
President, CEO and CFO |
• • – |
2017-02-02 |
4 |
A |
$0.00 |
$0 |
D/D |
31,250 |
167,610 |
0 |
- |
|
| ECYT |
Endocyte Inc |
President, CEO and CFO |
• • – |
2017-02-04 |
4 |
D |
$2.18 |
$6,741 |
D/D |
(3,092) |
164,518 |
0 |
- |
|
| ECYT |
Endocyte Inc |
President, CEO and CFO |
• • – |
2017-02-06 |
4 |
D |
$2.18 |
$1,509 |
D/D |
(692) |
163,826 |
0 |
- |
|
| ECYT |
Endocyte Inc |
President, CEO and CFO |
• • – |
2017-05-31 |
4 |
OE |
$2.10 |
$92,999 |
D/D |
44,285 |
208,111 |
0 |
- |
|
| ECYT |
Endocyte Inc |
President, CEO and CFO |
• • – |
2017-10-04 |
4 |
A |
$0.00 |
$0 |
D/D |
125,000 |
333,111 |
0 |
- |
|
32 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
